Hudson’s Bay under pressure from shareholders due to share price concern

By Jonathan Dyble
Share

Shareholders of Hudson’s Bay Co. (HBC) have voiced a number of concerns, including the firm’s stagnant share price and its operations in Europe.

Minority shareholder Land and Buildings Investment Management recently increased its shareholdings from 4.3% to 5%, giving it the power to call a shareholder meeting.

HBC has estimated that its own property holdings are value at $6.4bn, working out in excess of $35 per share. However, the company’s shares have most recently been selling for just $10.67.

With the share price down as much as 58.6% from August last year, Land and Buildings have called for a significant reform of HBC’s property holdings so that this value is reflected in the share price.

See Also:

 

Suggestions that shareholders have made to achieve this include the redevelopment of the flagship Saks Fifth Avenue store, withdrawal from Europe to focus on maximising potential in Canada, and privatisation of the firm.

Land and Buildings Investment Management Founder and CEO, Jonathan Litt, said that if adequate action is not taken then he will be intervening to protect the company’s investment interests.

“If left with no other choice, we believe it will be necessary to call a special meeting of shareholders to remove board members.”

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy